Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2b Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of MEDI3506 in Subjects With Diabetic Kidney Disease

NCT04170543 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT04170543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04170543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2b Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of MEDI3506 in Subjects With Diabetic Kidney Disease
Lead sponsor
AstraZeneca
Phase
Phase 2
Overall status
Completed
Start date
November 18, 2019
Completion date
May 16, 2023
Enrollment
609 (actual)
Sites
97

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic kidney disease